[Differentiating clinical characteristics in bacteriemia caused by Enterococcus faecalis or Enterococcus faecium]
- PMID: 19783077
- DOI: 10.1016/j.eimc.2009.06.011
[Differentiating clinical characteristics in bacteriemia caused by Enterococcus faecalis or Enterococcus faecium]
Abstract
Introduction: Enterococci are responsible for severe infections, such as endocarditis and bacteremia. During recent decades, enterococcal infections have grown in importance because of the increasing number of cases. Knowledge of the factors predisposing to acquisition of infection by E. faecalis or E. faecium may be useful to improve the empirical treatment.
Methods: Retrospective study of patients diagnosed with enterococcal bacteremia and hospitalized over a 7-year period (January 2000-December 2006), analyzing demographic data, clinical and microbiological characteristics, antibiotic exposure, treatment, and outcome. To identify the predisposing factors for isolation of E. faecalis or E. faecium in a clinical specimen, we performed univariate comparisons between the 2 groups, and subsequently, multivariate logistic regression analysis.
Results: A total of 228 episodes of bacteremia were recorded, 168 caused by E. faecalis and 60 by E. faecium. All E. faecalis isolates were susceptible to ampicillin, but only 25% of E. faecium were ampicillin-susceptible. There was only 1 vancomycin-resistant isolate. The variables independently associated with acquisition of E. faecium bacteriemia were surgical ward admission (odds ratio [OR], 4.223; P=.001), >5 days of previous treatment with cephalosporins (OR, 2.564; P=.013), >5 days of carbapenems (OR, 2.652; P=.027), previous administration of penicillins (OR, 2.008; P=0.044), SAPS score >30 at admission (OR, 3.530; P=0.001), and hepatobiliary disease as a comorbid condition (OR, 3.754; P<0.001),
Conclusion: Because of the differing susceptibility patterns of the enterococcal species studied, it is essential to know the factors predisposing to acquisition of infection by one or the other species to initiate adequate empirical treatment.
Copyright 2009 Elsevier España, S.L. All rights reserved.
Similar articles
-
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.J Microbiol Immunol Infect. 2008 Apr;41(2):124-9. J Microbiol Immunol Infect. 2008. PMID: 18473099
-
Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).Int J Antimicrob Agents. 2009 Jun;33(6):543-8. doi: 10.1016/j.ijantimicag.2008.12.007. Epub 2009 Feb 6. Int J Antimicrob Agents. 2009. PMID: 19201165
-
Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study.Clin Microbiol Infect. 2014 Feb;20(2):145-51. doi: 10.1111/1469-0691.12236. Epub 2013 May 6. Clin Microbiol Infect. 2014. PMID: 23647880
-
[Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].Enferm Infecc Microbiol Clin. 1991 Nov;9(9):547-50. Enferm Infecc Microbiol Clin. 1991. PMID: 1668361 Review. Spanish.
-
[Enterococcal endocarditis].Harefuah. 1996 Apr 15;130(8):548-50. Harefuah. 1996. PMID: 8765882 Review. Hebrew. No abstract available.
Cited by
-
Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2011-2022. doi: 10.1007/s10096-024-04917-5. Epub 2024 Aug 8. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39112668 Free PMC article.
-
Daptomycin versus Glycopeptides for the Treatment of Enterococcus faecium Bacteraemia: A Cohort Study.Antibiotics (Basel). 2021 Jun 14;10(6):716. doi: 10.3390/antibiotics10060716. Antibiotics (Basel). 2021. PMID: 34198646 Free PMC article.
-
Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China.J Huazhong Univ Sci Technolog Med Sci. 2017 Apr;37(2):257-263. doi: 10.1007/s11596-017-1725-9. Epub 2017 Apr 11. J Huazhong Univ Sci Technolog Med Sci. 2017. PMID: 28397040
-
Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients.Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):103-8. doi: 10.1007/s10096-010-1029-5. Epub 2010 Aug 15. Eur J Clin Microbiol Infect Dis. 2011. PMID: 20711795
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources